Target intelligence / Profile preview

Body composition

Molecular classification
Other (not a molecule/receptor/enzyme/transporter)
01

Overview

Body composition refers to the quantification of different components within the human body—primarily fat mass, lean tissue/muscle mass, bone mineral content, and water. Various models exist for its assessment: * Two-compartment model:* divides into fat mass and fat-free mass. * Multi-compartment models:* further separate water, protein/muscle tissue, minerals/bone content. Measurement techniques include skinfold calipers for subcutaneous fat estimation; bioelectrical impedance analysis; dual-energy X-ray absorptiometry (DXA); MRI/CT imaging; ultrasound-based methods. Accurate assessment provides insight into nutritional status and disease risk but does not represent a discrete molecular or pharmacological target. Rather than being targeted by drugs directly, changes in body composition result from lifestyle interventions or medications affecting metabolism/hormones.[7][5][1] In summary: Body composition should not be classified as a canonical drug target—it is an aggregate physiological measure rather than a specific molecular entity suitable for direct pharmacologic targeting.

Other names
Body fat percentageFat-free mass analysis (context-dependent)Compartmental body analysis
02

Biological functions

Indicator of nutritional statusAssessment of metabolic healthRisk stratification for diseases such as obesity and sarcopenia
03

Disease associations

ObesityMetabolic syndromeCardiovascular disease risk assessmentSarcopenia/frailty in aging populations
04

Safety considerations

Misinterpretation of results due to population differences or measurement errorOverreliance on indirect measures like BMI which do not distinguish between muscle and fat mass
05

Biomarkers

Body mass index (BMI) [though limited]Waist circumference/waist-to-height ratioDual-energy X-ray absorptiometry (DXA) measurements for fat/muscle/bone compartments

Beyond the preview

Go deeper on Body composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Body composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call